Four Red Flags Loom Over DHC’s Bull‑HighVol Surge

Historic drawdowns clash with strong alpha as risk mounts in the next 12 months

DHC Diversified Healthcare Trust

In this report

01

Returns Overview

Period returns, alpha, cumulative performance, distributions

P. 2-3

→

02

Volatility Analysis

Annualized volatility, downside deviation, drawdowns

P. 4-5

→

03

Beta & Correlation

Trailing, upside, downside beta, systematic risk

P. 6-7

→

04

Risk-Adjusted Returns

Sharpe, Sortino, Calmar, Information, Treynor

P. 8-9

→

05

Market Regime Analysis

Bull/bear behavior, capture ratios

P. 10-11

→

06

Investment Highlights & Risk Summary

Executive summary, risk flags, rankings

P. 12-13

→

Returns Overview

Diversified Healthcare Trust (DHC) — Return Performance

Diversified Healthcare Trust (DHC) delivered exceptionally strong returns across all horizons, markedly outpacing its XLRE sector benchmark. Over the past month it posted a 2.52% gain versus sector return of 0.91%, while over three months the excess was 18.99%; six‑month and one‑year periods showed even larger outperformance at 65.1% and 129.67% respectively. The cumulative five‑year total return of 122.72% dwarfs the sector’s 105.36%, reflecting a consistent ability to generate alpha in both short and long terms.

Period Returns vs S&P 500 & XLRE

Monthly Returns Heatmap

DHC

Across all intervals DHC produced positive alpha, with the magnitude expanding from 5.11% over one month to 263.67% over five years, indicating that its outperformance is not a short‑term anomaly but a sustained advantage. The most pronounced divergence appears in the three‑year and five‑year windows where alpha exceeds sector returns by 227.18% and 263.67%, respectively, underscoring DHC as a standout performer within XLRE.

Returns Overview

Diversified Healthcare Trust (DHC) — Return Charts

Volatility Analysis

Diversified Healthcare Trust (DHC) — Volatility Profile

Diversified Healthcare Trust (DHC) exhibits markedly higher price variability than the broader market, with an annualized volatility of 60.52% compared to the S&P 500’s 17.78%, indicating that its share price swings more than three times as much on a yearly basis. The fund’s downside risk metrics reinforce this picture: a downside deviation of 42.34% and a historical maximum drawdown of -96.34%—a loss spanning over six years from September 2016 to December 2022 with no full recovery—signal extreme vulnerability during adverse market regimes. While the recent 60‑day (40.08%) and 252‑day (40.46%) volatilities remain well below the long‑term average, they are still double the S&P 500’s typical short‑term volatility, suggesting that even in calmer periods DHC retains a pronounced risk profile relative to benchmark equities.

Volatility Metrics

DHC

The fund’s annualized volatility of 60.52% dwarfs the S&P 500’s 17.78%, meaning investors should expect substantially larger price swings and a higher risk premium for holding DHC. Downside deviation at 42.34% captures the magnitude of losses when markets turn south, while the -96.34% max drawdown reflects an almost total erosion of value over a six‑year span, underscoring severe tail risk. Although the trailing 60‑day (40.08%) and 252‑day (40.46%) volatilities are lower than the long‑term average, they remain elevated relative to the market, indicating that volatility has moderated but remains pronounced.

Annualized volatility of DHC is more than three times the S&P 500’s level.
Downside deviation of 42.34% points to large loss potential in bear markets.
Maximum drawdown of -96.34% over a six‑year period highlights extreme tail risk and lack of recovery.
Trailing 60‑day and 252‑day volatilities are below the long‑term average but still double typical market volatility.

Positive Characteristics
Recent volatility has eased from its historic peak, suggesting some stabilization in price movements.
The fund’s short‑term volatility remains lower than its own long‑term average, indicating a potential reduction in risk intensity.

Volatility Analysis

Diversified Healthcare Trust (DHC) — Volatility & Drawdown Charts

Beta & Correlation

Diversified Healthcare Trust (DHC) — Beta Profile

Diversified Healthcare Trust (DHC) exhibits a trailing market beta of 1.328, placing it in the aggressive range (>1.2). This indicates that the stock tends to move 32.8% more than the S&P 500 on average, amplifying both upside and downside market swings. However, its sector beta of 1.516 relative to the Real Estate index (XLRE) suggests an even stronger sensitivity to real‑estate dynamics, meaning a sizable portion of DHC’s volatility stems from sector‑specific factors rather than broad equity market movements. The asymmetric beta profile—upside beta of 1.231 versus downside beta of 1.529—highlights that DHC is more reactive to market declines than rallies, an important consideration for risk‑averse investors. An R-squared of 0.152 (correlation 0.39) with the S&P 500 shows that only about 15% of its price variance is explained by overall market movements, leaving roughly 85% driven by idiosyncratic forces. By contrast, the sector R-squared of 0.244 indicates a modestly higher, yet still limited, explanatory power from real‑estate trends.

Beta & Correlation Metrics

DHC

The trailing market beta of 1.328 classifies DHC as an aggressive equity, implying heightened exposure to macro‑economic cycles and potential for outsized returns when the broader market rallies. Its downside beta of 1.529 exceeds the upside beta of 1.231, signaling that losses in bearish environments may be more pronounced than gains in bullish periods, a key asymmetric risk characteristic. The sector beta of 1.516 underscores that DHC’s price action is even more tied to real‑estate sector movements than to the overall market, suggesting that sector-specific shocks—such as changes in property valuations or REIT regulatory shifts—could dominate its risk profile. With systematic risk accounting for only 15.2% of total variance and idiosyncratic risk at 84.8%, diversification benefits are limited; investors should treat DHC largely as a company‑specific exposure rather than a pure market proxy.

DHC’s market beta (1.328) is in the aggressive range, indicating amplified response to S&P 500 moves.
Downside beta (1.529) exceeds upside beta (1.231), revealing greater sensitivity to market declines.
Only 15% of price variance is explained by the broad market (R² 0.152), leaving most risk idiosyncratic.
Sector beta (1.516) is higher than market beta, showing that real‑estate sector dynamics dominate its volatility.
Idiosyncratic risk (84.8%) far outweighs systematic risk (15.2%), limiting diversification benefits.

Positive Characteristics
Aggressive market beta offers potential for outsized gains in rising equity markets.
Higher sector beta can be advantageous if the real‑estate sector outperforms its benchmark.
Low correlation with the S&P 500 (0.39) provides a diversification buffer against broad market downturns.

Beta & Correlation

Diversified Healthcare Trust (DHC) — Rolling Beta

Positive Notes

Aggressive market beta offers potential for outsized gains in rising equity markets.

Higher sector beta can be advantageous if the real‑estate sector outperforms its benchmark.

Low correlation with the S&P 500 (0.39) provides a diversification buffer against broad market downturns.

Risk-Adjusted Returns

Diversified Healthcare Trust (DHC) — Risk-Adjusted Performance

Diversified Healthcare Trust (DHC) delivers modest risk-adjusted returns over the measurement horizon, as reflected by a Sharpe ratio of 0.171 and a Treynor ratio of 7.813. While the Sharpe figure falls well below the benchmark threshold of 1.0, indicating that total risk‑adjusted performance is weak relative to the risk‑free rate, the Sortino ratio of 0.245 exceeds the Sharpe, suggesting that downside volatility is less pronounced than overall volatility. The Calmar ratio of 0.145 points to a relatively steep maximum drawdown compared with the fund’s annualized return, and an Information ratio of 0.022 signals minimal consistent alpha generation.

Risk-free rate: 3.63% (Fed Funds Rate)

Risk-Adjusted Metrics

DHC

The Sharpe ratio of 0.171 implies that DHC generates only $0.17 of excess return per unit of total volatility, a level that would be considered underperforming in most equity contexts. However, the higher Sortino ratio (0.245) indicates that the fund’s downside risk is lower than its overall risk profile, which may appeal to investors focused on capital preservation. The Calmar ratio of 0.145 reveals that the worst historical drawdown erodes a substantial portion of the annualized return, highlighting vulnerability during market stress. An Information ratio of 0.022 suggests that active management contributes negligible excess returns over the benchmark, reinforcing the view that the fund’s performance is largely driven by market exposure rather than skillful security selection.

Sharpe ratio well below 1.0 signals weak total risk‑adjusted return.
Sortino exceeds Sharpe, indicating a more favorable downside volatility profile.
Calmar ratio of 0.145 points to significant drawdown severity relative to returns.
Information ratio near zero reflects minimal consistent alpha generation.

Positive Characteristics
Downside risk is relatively contained as shown by the higher Sortino ratio.
Treynor ratio of 7.813 suggests a strong return per unit of systematic (beta) risk.

Risk-Adjusted Returns

Diversified Healthcare Trust (DHC) — Rolling Sharpe & Sortino

Positive Notes

Downside risk is relatively contained as shown by the higher Sortino ratio.

Treynor ratio of 7.813 suggests a strong return per unit of systematic (beta) risk.

Market Regime Analysis

Diversified Healthcare Trust (DHC) — Regime Behavior

Diversified Healthcare Trust (DHC) exhibits pronounced sensitivity to market volatility regimes. In a Bull-LowVol environment the trust delivers modest returns of 1.35% per month, reflecting limited upside when equity markets rise calmly. Conversely, during Bull-HighVol periods it generates an elevated average monthly return of 4.99%, indicating that heightened market turbulence amplifies its performance. The bear regimes reveal defensive characteristics: in Bear-LowVol months the trust suffers a steep decline of -13.64% on average, but the loss is markedly restrained to -1.72% during Bear-HighVol periods, suggesting resilience when markets fall sharply and erratically. The current Bull-HighVol regime—characterized by an S&P 500 above its 50‑day SMA yet with realized volatility above median—places DHC in its most favorable historical context.

Current Market Regime: Bull-HighVol

Bull-LowVol = calm uptrend • Bull-HighVol = volatile uptrend • Bear-LowVol = orderly decline • Bear-HighVol = crisis

Regime Returns & Capture Ratios

DHC

Under the prevailing Bull-HighVol regime, DHC’s average monthly return of 4.99% aligns with its strongest historical performance, driven by an upside capture of 143.1%. However, the downside capture remains high at 173.3%, yielding a capture ratio of 0.83, which signals that while the trust captures substantial market gains, it also absorbs disproportionate losses in down markets. In Bear-LowVol conditions the trust’s -13.64% average loss underscores vulnerability when declines are orderly and low‑volatility, whereas its modest -1.72% loss in Bear-HighVol suggests a defensive tilt during chaotic sell‑offs.

Market Regime Analysis

Diversified Healthcare Trust (DHC) — Regime & Capture Charts

Regime Timeline

DHC thrives in volatile uptrends, delivering nearly 5% average monthly returns in Bull-HighVol periods.
The trust’s downside capture of 173.3% exceeds its upside capture, resulting in a sub‑1.0 capture ratio and indicating higher loss sensitivity than gain potential.
Defensive performance is evident in Bear-HighVol regimes where losses are limited to -1.72%, contrasting sharply with the steep -13.64% decline in Bear-LowVol settings.

Positive Characteristics
Strong upside capture of 143.1% during market rallies enhances return potential when equity markets surge.
Resilience in Bear-HighVol environments suggests DHC can act as a partial hedge during periods of heightened market stress.

Investment Highlights & Risk Summary

Diversified Healthcare Trust (DHC) — Summary & Implications

Diversified Healthcare Trust delivered an extraordinary 1‑year total return of 139.6%, generating an alpha of 120.6% versus the S&P 500 and outpacing its real estate peer group by 129.7%. The performance reflects aggressive price appreciation, yet it came at a cost: annualized volatility of 60.5% and a historic maximum drawdown of –96.3% highlight severe downside risk. Risk metrics are modest, with a Sharpe ratio of 0.17 and a Sortino ratio of 0.25, indicating limited excess return per unit of total or downside risk. The trust’s capture profile—upside capture of 143.1% versus downside capture of 173.3%—shows that while it participates strongly in market rallies, it also magnifies losses during downturns, resulting in an unfavorable capture ratio below 1.0.

Summary Dashboard

Investment Highlights

Absolute return of 139.6% over the past year represents a rare high‑growth episode for a REIT, driven by strong demand for healthcare properties.
Sector alpha of 129.7% versus XLRE demonstrates that the trust has significantly outperformed its real‑estate peers, reflecting superior property acquisition and leasing dynamics.
Upside capture of 143.1% indicates that the trust captures more than the full upside when the broader market rises, contributing to its impressive return profile.

Risk-Return Rankings

DHC HIGH

Exceptional 1‑year return with strong sector outperformance but accompanied by extreme volatility and drawdown risk.

Strength: Sector alpha of +129.7% versus XLRE, highlighting superior relative performance.

Concern: Maximum historical drawdown of –96.3% signals potential for near‑total capital loss during adverse market conditions.

Key Takeaways

The trust’s return story is driven by aggressive price appreciation rather than stable cash flow generation.
High volatility (60.5%) and a Sharpe ratio well below 1.0 suggest that excess returns are not efficiently compensated for risk.
Downside capture exceeding 170% means the stock amplifies market declines, raising concerns for risk‑averse investors.
Investors should monitor liquidity and tenant credit quality in healthcare properties, as these can exacerbate drawdown risk.

PORTFOLIO IMPLICATIONS

Given its high return potential but pronounced downside exposure, Diversified Healthcare Trust may serve as a satellite position within a diversified portfolio that already contains low‑beta, income‑focused assets. Its asymmetric upside capture can add growth when the market is bullish, yet the deep drawdown history warrants limiting allocation size and pairing it with defensive holdings to mitigate overall portfolio volatility.

DHC

Related Reports

Visit finexus.net/reports for more reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.